Fieldview Capital Management LLC bought a new position in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 3,099 shares of the company’s stock, valued at approximately $486,000.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of CAH. SJS Investment Consulting Inc. grew its stake in Cardinal Health by 1,363.6% during the third quarter. SJS Investment Consulting Inc. now owns 161 shares of the company’s stock worth $25,000 after buying an additional 150 shares during the period. Jones Financial Companies Lllp increased its position in shares of Cardinal Health by 198.3% in the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after acquiring an additional 14,034 shares in the last quarter. American Capital Advisory LLC raised its stake in shares of Cardinal Health by 5,200.0% in the 3rd quarter. American Capital Advisory LLC now owns 212 shares of the company’s stock valued at $33,000 after acquiring an additional 208 shares during the period. Vermillion & White Wealth Management Group LLC lifted its holdings in shares of Cardinal Health by 55.0% during the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 200 shares of the company’s stock valued at $34,000 after acquiring an additional 71 shares in the last quarter. Finally, Quent Capital LLC acquired a new position in shares of Cardinal Health during the 3rd quarter valued at $35,000. 87.17% of the stock is owned by institutional investors and hedge funds.
Cardinal Health Price Performance
Cardinal Health stock opened at $216.91 on Wednesday. Cardinal Health, Inc. has a 12-month low of $120.72 and a 12-month high of $233.60. The company has a market capitalization of $51.04 billion, a price-to-earnings ratio of 31.21, a price-to-earnings-growth ratio of 1.43 and a beta of 0.65. The firm’s fifty day moving average price is $216.14 and its 200 day moving average price is $191.03.
Cardinal Health Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 15th. Shareholders of record on Wednesday, April 1st will be paid a dividend of $0.5107 per share. This represents a $2.04 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Wednesday, April 1st. Cardinal Health’s dividend payout ratio (DPR) is 29.35%.
Wall Street Analysts Forecast Growth
Several analysts recently issued reports on CAH shares. Weiss Ratings reiterated a “buy (b)” rating on shares of Cardinal Health in a report on Wednesday, January 21st. Evercore boosted their price objective on Cardinal Health from $250.00 to $260.00 in a research note on Friday, February 6th. Robert W. Baird set a $252.00 target price on Cardinal Health in a research report on Friday, February 6th. Morgan Stanley set a $255.00 target price on Cardinal Health in a research note on Friday, February 6th. Finally, Leerink Partners reiterated an “outperform” rating and set a $275.00 target price on shares of Cardinal Health in a report on Monday. One investment analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $245.67.
View Our Latest Research Report on Cardinal Health
Cardinal Health Profile
Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.
The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.
Featured Articles
- Five stocks we like better than Cardinal Health
- The gold chart Wall Street is terrified of…
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.
